The presence of FOXK2 is linked to the metastasis of colorectal cancer, and the drug cetuximab can disrupt the feedback loop involving EGF NF‐κB–FOXK2–EGFR, thus preventing metastasis in CRC.32 The gene discussed is NFKB1; the disease is colorectal cancer.